Your browser doesn't support javascript.
loading
Low Z-4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen.
Helland, Thomas; Naume, Bjørn; Hustad, Steinar; Bifulco, Ersilia; Kvaløy, Jan Terje; Saetersdal, Anna Barbro; Synnestvedt, Marit; Lende, Tone Hoel; Gilje, Bjørnar; Mjaaland, Ingvil; Weyde, Kjetil; Blix, Egil Støre; Wiedswang, Gro; Borgen, Elin; Hertz, Daniel Louis; Janssen, Emiel Adrianus Maria; Mellgren, Gunnar; Søiland, Håvard.
Afiliação
  • Helland T; Hormone Laboratory, Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, Bergen, Norway.
  • Naume B; Department of Clinical Science, University of Bergen, Norway.
  • Hustad S; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Norway.
  • Bifulco E; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Norway.
  • Kvaløy JT; Core Facility for Metabolomics, Department of Clinical Science, University of Bergen, Norway.
  • Saetersdal AB; Core Facility for Metabolomics, Department of Clinical Science, University of Bergen, Norway.
  • Synnestvedt M; Department of Mathematics and Physics, University of Stavanger, Norway.
  • Lende TH; Department of Research, Stavanger University Hospital, Norway.
  • Gilje B; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Norway.
  • Mjaaland I; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Norway.
  • Weyde K; Department of Surgery, Section for Breast and Endocrine Surgery, Stavanger University Hospital, Norway.
  • Blix ES; Department of Oncology and Radiotherapy, Stavanger University Hospital, Norway.
  • Wiedswang G; Department of Oncology and Radiotherapy, Stavanger University Hospital, Norway.
  • Borgen E; Department of Oncology, Sykehuset Innlandet, Gjøvik, Norway.
  • Hertz DL; Immunology Research Group, Institute of Medical Biology, University of Tromsø, Norway.
  • Janssen EAM; Department of Oncology, University Hospital of North Norway, Tromsø, Norway.
  • Mellgren G; Department of GI-Surgery, Oslo University Hospital, Norway.
  • Søiland H; Department of Pathology, Oslo University Hospital, Norway.
Mol Oncol ; 15(4): 957-967, 2021 04.
Article em En | MEDLINE | ID: mdl-33252186
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tamoxifeno / Neoplasias da Mama / Antineoplásicos Hormonais Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tamoxifeno / Neoplasias da Mama / Antineoplásicos Hormonais Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article